SIC 2835 – In Vitro and In Vivo Diagnostic Substances
| Valuation | |
|---|---|
| Market Cap ($M) | 11.97 |
| Enterprise Value ($M) | 11.56 |
| Book Value ($M) | -2.52 |
| Book Value / Share | -0.16 |
| Price / Book | -4.75 |
| NCAV ($M) | -3.17 |
| NCAV / Share | -0.20 |
| Price / NCAV | -3.78 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -1.71 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.70 |
| Current Ratio | 0.75 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.11 |
| Assets | 4.76 |
| Liabilities | 7.28 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Dilutive Effect Of Stock Options | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 7.76 | ||
| 13D/A | Schuler Jack W | 14.00 | 0.34 | |
| 13G/A | Schultz Eric Adam | 4.41 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 15,474 | 82,888 | 18.67 | |
| 6,159 | 28,343 | 21.73 | |
| 26,477 | 50,229 | 52.71 | |
| 43,935 | 167,352 | 26.25 | |
| 2,459 | 53,146 | 4.63 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ATXI – Avenue Therapeutics, Inc. | ATYR – aTyr Pharma, Inc. |
| AVTX – Avalo Therapeutics, Inc. | AYTU – Aytu BioPharma, Inc. |
| BCDA – BioCardia, Inc. |
Financial data and stock pages provided by
Fintel.io